Log in

BKHA Black Hawk Acquisition Corp NASDAQ · United States

Black Hawk Acquisition (BKHA) news

Black Hawk Acquisition Corp is a public biotech or pharmaceutical company listed on NASDAQ under the ticker BKHA, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest Black Hawk Acquisition news

We have not published a story on Black Hawk Acquisition yet. When there is news, it will appear here.

Black Hawk Acquisition annual financials

LineFY ended Nov 30, 2025FY ended Nov 30, 2024
Net income (loss)$1.3 million$1.9 million
Cash from operations-$650,321-$553,665
Cash and equivalents$0$0

Latest balance sheet, Aug 31, 2026 (10-Q): cash and equivalents $0.

Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice.

Questions about Black Hawk Acquisition

What is the ticker symbol of Black Hawk Acquisition?

Black Hawk Acquisition Corp trades under the ticker BKHA on NASDAQ.

Where is Black Hawk Acquisition listed?

Black Hawk Acquisition Corp is listed on NASDAQ.

Which country or territory is Black Hawk Acquisition listed under?

Our directory records Black Hawk Acquisition Corp under United States.

Does aibio.space cover Black Hawk Acquisition?

aibio.space lists Black Hawk Acquisition Corp among 2,820 public biotech companies and publishes its news here as stories appear.

Is Black Hawk Acquisition profitable?

Black Hawk Acquisition Corp reported net income of $1.3 million for the fiscal year ended Nov 30, 2025, and used $650,321 of cash in operations, per its annual report to the SEC.

How much cash does Black Hawk Acquisition have?

$0 in cash at Aug 31, 2026, per its 10-Q.

Investor discussion: Black Hawk Acquisition

Members talk about Black Hawk Acquisition (BKHA). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Capital-markets timeline

Financings, listing notices, splits, legal actions and other investor events at Black Hawk Acquisition, newest first. Each line links the filing it comes from.

  1. Mergers

    Reported a merger or acquisition agreement. SEC Form 8-K (Items 1.01,3.02,9.01). Source

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open NASDAQ:BKHA on TradingView.

Listing details

Black Hawk Acquisition Corp is a public biotech or pharmaceutical company listed on NASDAQ under the ticker BKHA, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
Black Hawk Acquisition Corp
Ticker
BKHA
Listing
NASDAQ
Country or territory
United States

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.